<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25427">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775747</url>
  </required_header>
  <id_info>
    <org_study_id>PRP-CS</org_study_id>
    <nct_id>NCT02775747</nct_id>
  </id_info>
  <brief_title>PRP Gel in Wound Closure in Recurrent CS</brief_title>
  <acronym>PRP-CS</acronym>
  <official_title>Platelet Rich Plasma Gel in Wound Closure in Recurrent Cesarean Section:Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is limited application of the use of PRP in obstetrics, therefore there is a need for
      assessment if it is efficacy in improving skin wound healing in cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to assess the efficacy of injection of platelet rich plasma into the wound
      of recurrent cesarean section for improving wound healing and enhancing the shape of the
      wound in women undergoing cesarean section.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of PRP in Wound healing in cesarean section by 100 mm visual analog scale</measure>
    <time_frame>one month</time_frame>
    <description>Efficacy of PRP in Wound healing in cesarean section by 100 mm visual analog scale (VAS) for wound healing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of the Cosmetic results of the wound by Modified Vancouver scar scale</measure>
    <time_frame>one month</time_frame>
    <description>Assessment of the Cosmetic results of the wound by Modified Vancouver scar scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Previous Incision</condition>
  <condition>Scar; Previous Cesarean Section</condition>
  <arm_group>
    <arm_group_label>platelet rich plasma gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of Platelet rich plasma (PRP) gel in 64 cases at time of wound closure in women undergoing cesarean section for improving wound healing after fullfit to all the inclusion and exclusion craiteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>64 Controlled Women with recurrent cesarean section and fullfit to all the inclusion and exclusion craiteria will reseve saline injection at time of wound closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>platelet rich plasma gel</intervention_name>
    <description>Platelet rich plasma is prepared from fresh whole blood which is collected from a peripheral vein stored in acid citrare dextrose solution A (ACD-A)anticoagulant and processed to increase platelets by separating various components of blood</description>
    <arm_group_label>platelet rich plasma gel</arm_group_label>
    <other_name>PRP</other_name>
    <other_name>platelete rich plasma (PRP)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>64 controlled women with recurrent cesarean section and fullfit to all inclusion and exclusion craiteria will reseve saline injection at time of wound closure</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective cesarean section

          -  Body mass index 18:25

          -  Hemoglobin more than 10.5 g/d

          -  Albumin within normal more than or equal 3.5 g/d

        Exclusion Criteria:

          -  medical disorders(Diabetes mellitus,heart disease,hypertension,systemic lupus
             erythematosus)

          -  high risk pregnancy as (placenta previa,placenta accreta)

          -  patient on corticosteroids medication

          -  primigravida subjected cesarean section

          -  complicated cesarean section (increased operation time,blood transfusion, drain,
             scrubbing of multiple surgeons)

          -  cesarean section due to chorioaminionitis

          -  postoperative complication such as:postpartum hemorrhage, paralytic ileus, sever
             distention..) will be dropped out from the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RASHA DR MEDHAT, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rasha M Abdul-hady, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>rasha Dr medhat, MD</last_name>
    <phone>1224448449</phone>
    <phone_ext>0020</phone_ext>
    <email>RASHAMEDHAT30@GMAIL.COM</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nour DR Elskhily, MSC</last_name>
    <phone>1062104656</phone>
    <phone_ext>0020</phone_ext>
    <email>nour2610@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rasha</name>
      <address>
        <city>Cairo</city>
        <state>Al Qahirah</state>
        <zip>002</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rasha M Abdul-hady, MD</last_name>
      <phone>1224448449</phone>
      <phone_ext>0020</phone_ext>
      <email>rashamedhat30@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>nour H Elskhily, MSC</last_name>
      <phone>1062104656</phone>
      <phone_ext>0020</phone_ext>
      <email>nour2610@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>May 14, 2016</lastchanged_date>
  <firstreceived_date>May 7, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>rasha medhat abdul-hady</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
